Senti Biosciences
SNTI
SNTI
23 hedge funds and large institutions have $27.8M invested in Senti Biosciences in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.16% less ownership
Funds ownership: 3.24% → 3.08% (-0.16%)
37% less capital invested
Capital invested by funds: $44.4M → $27.8M (-$16.5M)
Holders
23
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$924K | |
| 2 | +$301K | |
| 3 | +$248K | |
| 4 |
TM
Triatomic Management
Palo Alto,
California
|
+$123K |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$99.7K |
Top Sellers
| 1 | -$1.49M | |
| 2 | -$1.3M | |
| 3 | -$396K | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$249K |
| 5 |
VF
Virtu Financial
New York
|
-$43K |